Does ECULIZUMAB Cause Blindness transient? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Blindness transient have been filed in association with ECULIZUMAB (SOLIRIS). This represents 0.0% of all adverse event reports for ECULIZUMAB.
12
Reports of Blindness transient with ECULIZUMAB
0.0%
of all ECULIZUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Blindness transient From ECULIZUMAB?
Of the 12 reports, 2 (16.7%) required hospitalization.
Is Blindness transient Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Blindness transient?
AFLIBERCEPT (987)
ADALIMUMAB (200)
METFORMIN (153)
DIMETHYL (119)
INTERFERON BETA-1A (102)
NATALIZUMAB (101)
RANIBIZUMAB (100)
BROLUCIZUMAB-DBLL (99)
FINGOLIMOD (89)
BEVACIZUMAB (72)
Which ECULIZUMAB Alternatives Have Lower Blindness transient Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB